BMJ Rapid Recommendation: Thyroid hormone treatment for patients with subclinical hypothyroidism

Published by Ton Kuijpers, Trudy Bekkering, Thomas Agoritsas, Mieke Vermandere on May 15, 2019

Disclaimer

Sponsors

This guideline was not funded.

Contact

Abstract

A BMJ-Rapid Recommendation on Thyroid hormone therapy for patients with subclinical hypothyroidism. Roles: Panel Chair: Mieke Vermandere Methods co-chair: Ton Kuijpers Oversight from RapidRecs executive: Thomas Agoritsas, Gordon Guyatt, Reed Siemieniuk, Per Olav Vandvik

Language

en

PICOS

PICO 1.1

Population
Patients with subclinical hypothyroidism ,
Intervention
Thyroid hormone (levothyroxine mostly) ,
Comparator
No treatment or placebo ,
Outcomes
,

PICO 1.2

Population
Patients with subclinical hypothyroidism - TRUST-trial excluded, but only used as indirect evidence for mortality, cardiovascular accidents, serious adverse events, side effects and fatigue ,
Intervention
Thyroid hormone (levothyroxine mostly) ,
Comparator
No treatment or placebo ,
Outcomes
,